Johnson & Johnson

NYSE:JNJ   3:59:58 PM EDT
170.37
+1.87 (+1.11%)
4:00:03 PM EDT: $170.53 +0.16 (+0.09%)
Earnings Announcements

Johnson & Johnson Enters Agreement With GRAM To Manufacture SARS-CoV-2 Vaccine Candidate

Published: 09/25/2020 13:14 GMT
Johnson & Johnson (JNJ) - Grand River Aseptic Manufacturing - Entered Agreement With Janssen Pharmaceuticals to Support Manufacture of Its Sars-cov-2 Vaccine Candidate.
Grand River Aseptic Manufacturing - Agreement Includes Technical Transfer & Fill and Finish Manufacture of J&j's Sars-cov-2 Vaccine Candidate.
Revenue is expected to be $22.52 Billion
Adjusted EPS is expected to be $2.29

Next Quarter Revenue Guidance is expected to be $23.45 Billion
Next Quarter EPS Guidance is expected to be $2.40

More details on our Analysts Page.